Fulcrum Therapeutics, Inc.
USD3.75
+0.02 (+0.54%)
CEO
Alexander C. Sapir
IPO Date
2019-07-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.80
Prev. Close
$3.73
Day Low
$3.69
Day High
$3.80
52W Low
$2.83
52W High
$15.74
Market Cap
$0.20B
Volume
0.05M
| -30.0 |
| 31 Dec 2023 | FY | 100.0% | -3470.1% | -41.4% | -37.8% | 0.05 | 17.71 | -4.3 |
| 31 Dec 2022 | FY | -1110.7% | -1732.4% | -55.2% | -48.5% | 0.07 | 12.41 | -3.0 |
| 31 Dec 2021 | FY | -263.7% | -421.9% | -38.2% | -34.4% | 0.00 | 11.77 | -7.7 |
| 31 Dec 2020 | FY | -569.2% | -802.7% | -74.4% | -54.7% | 0.00 | 4.23 | -4.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -94.9% | -74.9% | 0.00 | 8.24 | -4.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -42.9% | -38.0% | 0.00 | 17.52 | -7.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -1737.1% | -529.1% | 26.16 | 0.48 | -10.0 |
| -8.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -9.9% | -9.1% | 0.04 | 17.70 | -7.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -8.1% | -7.6% | 0.04 | 24.42 | -6.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -7.7% | -7.3% | 0.04 | 28.71 | -2.5 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -6.8% | -6.4% | 0.04 | 22.63 | -3.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -8.4% | -7.8% | 0.04 | 18.44 | -2.6 |
| 30 Jun 2024 | Q2 | 78.4% | 69.3% | 20.2% | 18.8% | 0.04 | 22.07 | 1.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -12.6% | -11.6% | 0.05 | 20.38 | -5.4 |
| 31 Dec 2023 | Q4 | 41.7% | -2842.3% | -10.5% | -9.6% | 0.05 | 17.71 | -4.2 |